The widespread use of antibiotics as a weapon against microbial-driven disease has led to a world crisis of antimicrobial resistance, with consequences that could only be addressed in a global fashion due to its transnational extent. The international public health regime has made significant efforts to address the situation through a scheme that could be analyzed as a securitization process, identifying such resistance as a threat to international security under the scope of Human Security. Nevertheless, the recent increasing trends in pathogen resistance, as well as a slow pace in the development of new antibiotics prove these efforts to be failing. This paper intends to expose the disconnection between the efforts made by the regime and the worrying results in antimicrobial resistance trends. In order to do this, the text argues that the international process of securitization has failed to address the threat of Anti-Microbial Resistance as a security issue due to its absence of an appropriate risk management approach to implementation.
